Search hospitals > Wisconsin > Rice Lake

Marshfield Medical Center-Rice Lake

Claim this profile
Rice Lake, Wisconsin 54868
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
293 reported clinical trials
23 medical researchers
Photo of Marshfield Medical Center-Rice Lake in Rice LakePhoto of Marshfield Medical Center-Rice Lake in Rice LakePhoto of Marshfield Medical Center-Rice Lake in Rice Lake

Summary

Marshfield Medical Center-Rice Lake is a medical facility located in Rice Lake, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Marshfield Medical Center-Rice Lake is involved with conducting 293 clinical trials across 444 conditions. There are 23 research doctors associated with this hospital, such as Seth O. Fagbemi, Adedayo A. Onitilo, Chady A. Leon, MD, and Demet Gokalp Yasar.

Area of expertise

1Cancer
Global Leader
Marshfield Medical Center-Rice Lake has run 121 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Marshfield Medical Center-Rice Lake has run 41 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
ER positive
Stage IV

Top PIs

Clinical Trials running at Marshfield Medical Center-Rice Lake

Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Prostate Cancer
Renal Cell Carcinoma
Bladder Carcinoma
Squamous Cell Carcinoma
Multiple Myeloma
Rectal Cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Marshfield Medical Center-Rice Lake?
Marshfield Medical Center-Rice Lake is a medical facility located in Rice Lake, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Marshfield Medical Center-Rice Lake is involved with conducting 293 clinical trials across 444 conditions. There are 23 research doctors associated with this hospital, such as Seth O. Fagbemi, Adedayo A. Onitilo, Chady A. Leon, MD, and Demet Gokalp Yasar.